Emerging Markets - Branded Generics

Ajanta Pharma is an established player in emerging markets with presence in more than 30 countries spread across Africa, South East Asia, West Asia and CIS.

We have built an outstanding brand equity in these markets with sales being driven by its Branded Generic products.

Today Ajanta has strong ground presence in all these markets where the brand promotion is done by our own sales team. We have more than 200 brands in these markets and large number of them hold sizeable market share and enjoy leadership positions.

Ajanta has acquired strong capabilities of identifying gaps in its market place, obtaining the regulatory approvals for new products and then launching them successfully to make them into sizeable brand.  Our sales and marketing capabilities are 2nd to none having laser focused determination on execution.

In Emerging Markets, we have presence in wide range of therapeutic segments like, Cardiology, Anti-Diabetes, Ophthalmology, Antibiotic, Anti-Malarial, Pain, Respiratory, Gynaecology, Paediatric and General Health products. 

We have robust product pipeline under regulatory approvals in these markets which will further consolidate our leadership positions in sub-therapeutic and therapeutic segments.